Project: Long-term imaging of organ-on-chip cultures: a proof-of-concept for metastatic melanoma-on-chip

Acronym IMAGINe (Reference Number: 11275)
Duration 01/03/2018 - 28/02/2021
Project Topic IMAGINe will develop a device for long-term imaging of organ-on-chip (OoC) applications. This enabling technology controls the environment (e.g. temperature, fluid flow) of OoC cultures to keep these viable during imaging. The IMAGINe device uniquely enables the long-term monitoring of cellular processes in the OoC. This will be validated using a human skin-on-chip and a metastatic melanoma-on-chip model, in combination with novel cell-based therapeutics to inhibit metastasis.
Network Eurostars 2
Call Eurostars Cut-Off 7

Project partner

Number Name Role Country
1 Cherry Biotech SAS Coordinator France
2 IPD Therapeutics BV (traded as Glycostem Therapeutics) Partner Netherlands
3 Stichting VUmc Partner Netherlands